NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue:
Artificial Organs - Worldwide Market Challenges & Opportunities
Advertisement
http://www.reportlinker.com/p0164217/Artificial-Organs---Worldwide-Market-Challenges--Opportunities.html
With decades of research and advances in technology, artificial organs have become the viable alternative to effectively address donor organ shortage problem. Besides sustaining life and minimizing disease burden, artificial organs have been playing a crucial role in enhancing patient's quality of life. Additionally, artificial organs are not only enhancing patient outcomes and accelerating recovery times, but also minimizing overall healthcare expenditure. However, only few implantable devices have been approved for clinical use, while several others are still in clinical trials awaiting approvals.
Advertisement
With increasing number of patients suffering from late-stage diseases, organ failure has been accounting for the largest chunk of worldwide medical spending. On the other hand, the rising success rate of transplantation has been dramatically fuelling organ failure patients to opt for artificial organs. However, as organ recipients continue to rise, patient population on the waiting list is also expanding. The imbalance between number of receivers and donor organs has compelled the healthcare sector to search for other alternatives.
These and other market data and trends are presented in "Artificial Organs: Worldwide Market Challenges & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
ARTIFICIAL ORGANS BMR-1017
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. INDUSTRY OVERVIEW 4
Artificial Organs Revolutionize Medical Technology Industry 4
Current and Future Analysis 4
Market Outlook 5
Opportunities Abound for Bioartificial Organs 6
Bionics to Play Crucial Role 6
Economic Situation Plays a Pivotal Role in ESRD Treatment
Accessibility 7
Growth Drivers 7
Growth Inhibitors 8
3. MARKET TRENDS AND ISSUES 9
Higher Development Costs and Lengthy Regulatory Process -
Stumbling Blocks- for Product Commercialization 9
Lack of Requisite Expertise - Hindering Implantation Process 9
Alliances to Play a Key Role 10
Aging Population - A Boosting Factor 10
Anemia - A Growing Concern among Renal Failure Patients 10
Swelling ESRD Patient Population Spurs Dialyzers Growth 10
Growing Need for Efficient Control and Easy Usage 11
Expiry of Warranty Provides New Opportunities 11
Xenotransplantation - Other Alternative to Donor Organ Shortage 11
Artificial Organs from Cloned Animal Cells - A Promising Trend 11
Immunosuppressants Hold Promise in Artificial Organs Market 12
Move Towards Smaller Implantable Devices 12
Barriers to Entry Significantly High in Dialyzers Market 12
Reuse of Dialyzers - A Major Issue in Dialysis Industry 12
Poor Reimbursement Environment Stymies Innovation 13
Pricing Trends in Artificial Organs 13
4. COMPETITIVE SCENARIO 14
Competition Heating Up in Artificial Pancreas Domain 14
Fresenius Medical Care - Leads the Worldwide Dialysis
Equipment and Supplies- Market 15
Competitive Landscape of Artificial Kidney or Dialyzers Market 16
Synthetic Dialyzers to Attain Mainstay 16
Asahi Kasei Medical Dominates Japanese Dialyzers Market 17
Competitive Landscape of Ventricular Assist Devices 18
Liver Assist Devices Competitive Landscape 18
5. PRODUCT FACTS 19
Artificial Organs 19
Artificial Heart 20
Artificial Kidneys 20
Artificial Liver 20
Artificial Pancreas 20
Artificial Lungs 20
Organ Rejection - A Major Barrier to Transplantation 21
Other Issues for Organ Transplantation 21
Combined Organ Transplantation - Gaining Attention 21
6. REGULATORY ENVIRONMENT 22
Regulatory Environment in the US 22
Regulatory Environment in Europe 23
7. CORPORATE DEVELOPMENTS 24
Thoratec Receives FDA Approval for HeartMate II® 24
Asahi Kasei Institutes a Sales Subsidiary in Taiwan 24
Arbios Seeks CE Marking for SEPET(TM) 25
Gambro Teams up with Debiotech for Developing Peritoneal
Dialysis Cycler 25
Arbios Obtains US FDA Approval for Initiating Clinical Trial
for SEPET(TM) 25
Abiomed Obtains HDE Supplement Approval from FDA for AbioCor
®- Implantable Artificial Heart 25
Ventracor Obtains CE Marking for VentrAssist(TM) LVAD 26
Fresenius Medical Care Takes Over Renal Solutions, Inc. 26
Arbios Inks Exclusive Agreement with NxStage for SEPET(TM) 26
WorldHeart Completes First Multi-Day Animal Study of
PediaFlow(TM) VAD 26
Xcorporeal Completes Merger with CT Holdings 27
Nikkiso Collaborates with Nipro for Overseas Launch of
Dialysis Systems 27
Ege University to Initiate Artificial Heart Project 27
Vascutek Buys Kohler Chemie's Heart Valve Business 27
NovaThera Partners with NovaLung to Develop Advanced
Artificial Lung 27
Aksys Quits Kidney Dialysis Machines Business 28
Twardowski Terminates License Agreement with Aksys 28
Asahi Kasei Medical Fortifies Competence in Artificial Kidney
Production 28
Fresenius Medical Care Enhances Dialyzer Output 28
HepaLife Appoints Stem Cell Systems for Bioreactor Development 28
Gambro Unveils AK 96(TM) Dialyzer 29
Nipro Introduces Artificial Kidney Dialyzer in Overseas Markets 29
University of Michigan Develops Artificial Lungs 29
USC Researchers Develop Argus II Retinal Prosthesis System for
Retinal Implant 29
Researchers Develop Cell Manipulation Technique for Organ
Regeneration- Process 30
Terumo to Introduce First CE Mark LVAS in Europe 30
Advanced Technique for Nerve Re-Growth Developed 30
8. MAJOR PLAYERS 31
Abbott Diabetes Care (USA) 31
Abiomed, Inc. (USA) 31
Arbios Systems, Inc. (USA) 31
Asahi Kasei Kuraray Medical Co., Ltd (Japan) 31
Baxter International, Inc. (USA) 32
F.Hoffmann-La Roche Ltd. (Switzerland) 32
Fresenius Medical Care AG & Co. KgaA (Germany) 32
Fresenius Medical Care North America Inc (USA) 32
Fresenius Kawasumi (Japan) 32
Gambro AB (Sweden) 33
Hepalife Technologies, Inc. (USA) 33
Jarvik Heart, Inc. (USA) 33
MC3, Inc. (USA) 33
Medtronic, Inc. (USA) 33
MicroMed Cardiovascular, Inc. (USA) 33
Nikkiso Co., Ltd. (Japan) 34
Nipro Corporation (Japan) 34
SynCardia Systems, Inc. (USA) 34
Terumo Corporation (Japan) 34
Thoratec Corporation (USA) 35
Toray Medical Co., Ltd. (Japan) 35
Ventracor Limited (Australia) 35
Vital Therapies, Inc. (USA) 35
WorldHeart Corporation (USA) 35
9. GLOBAL MARKET ANALYTICS 36
EXHIBITS
Table 1: Percentage Breakdown of Leading Players in the
Worldwide Dialysis Equipment and Supplies Market by Sales-
2006
Table 2: Percentage Breakdown of Leading Players in the
Worldwide Hemodialysis Equipment and Supplies Market by Sales
- 2006
Table 3: Percentage Breakdown of Leading Players in the
Worldwide Peritoneal Dialysis Equipment and Supplies Market by
Sales - 2006
Table 4: Percentage Breakdown of Leading Players in the
Worldwide Dialyzers Market by Unit Output - 2007
Table 5: Percentage Breakdown of Leading Players in the
Japanese Kidney Dialyzers Market by Sales - 2006
Table 6: Percentage Breakdown of Leading Players in the
Worldwide VADs Market by Sales - 2006
Table 7: Global Artificial Organs Market by Product Segment
for the Period 2007-2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Artificial Organs
Market by Product Segment for the Years 2008 & 2012
Table 9: Global Artificial Kidneys/Dialyzers Market by Region
for the Period 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Artificial
Kidneys/Dialyzers Market by Region for the Years 2008 & 2012
Table 11: Global Insulin Pumps (External) Market by Region for
the Period 2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of Global Insulin Pumps
(External) Market by Region for the Years 2008 & 2012
COMPANIES PROFILED
To order this report:
Medical Equipment and Supply Industry: Artificial Organs - Worldwide Market Challenges & Opportunities
More Market Research Report
Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
